Oriola-kd traded at 1.13 this Monday February 23rd, decreasing 0.01 or 0.53 percent since the previous trading session. Looking back, over the last four weeks, Oriola-kd lost 6.14 percent. Over the last 12 months, its price rose by 17.18 percent. Looking ahead, we forecast Oriola-kd to be priced at 1.11 by the end of this quarter and at 1.02 in one year, according to Trading Economics global macro models projections and analysts expectations.
Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The Company is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.